Caryl E. Sortwell, Ph.D.

Affiliations: 
Translational Science & Molecular Medicine Michigan State University, East Lansing, MI 
Area:
Parkinson's disease therapeutics
Google:
"Caryl Sortwell"
Mean distance: 16.69 (cluster 19)
 
SNBCP
Cross-listing: Neuropathology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Centner A, Del Priore I, Chambers N, et al. (2024) Deficits in basal and evoked striatal dopamine release following alpha-synuclein preformed fibril injection: An in vivo microdialysis study. The European Journal of Neuroscience
Stoll AC, Kemp CJ, Patterson JR, et al. (2024) Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions. Neurobiology of Disease. 106411
Patterson JR, Kochmanski J, Stoll AC, et al. (2024) Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils. Npj Parkinson's Disease. 10: 7
Collier TJ, Begg L, Stancati JA, et al. (2023) Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipine. Experimental Neurology. 114522
Boyd SL, Kuhn NC, Patterson JR, et al. (2023) Developmental exposure to the Parkinson's disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice. Toxicological Sciences : An Official Journal of the Society of Toxicology
Stoll AC, Kemp CJ, Patterson JR, et al. (2023) Microglial depletion does not impact alpha-synuclein aggregation or nigrostriatal degeneration in the rat preformed fibril model. Research Square
Caulfield ME, Vander Werp MJ, Stancati JA, et al. (2023) Downregulation of striatal Ca1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age. Neurobiology of Disease. 181: 106111
Fischer DL, Auinger P, Goudreau JL, et al. (2022) rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease. Frontiers in Neurology. 13: 1053591
Patterson JR, Cole-Strauss A, Kuhn N, et al. (2022) Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling. Journal of Visualized Experiments : Jove
Patterson JR, Hirst WD, Howe JW, et al. (2022) Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. Npj Parkinson's Disease. 8: 61
See more...